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Chapter 12
The aim of this thesis was to get a deeper understanding of the co-occurrence of 
depressive, anxiety and somatic symptoms. The first part focused on epidemiological 
aspects of this co-occurrence, while the second part examined its clinical aspects 
in consultations and interventions. In this chapter, we draw up the balance. What do 
the results tell us about the map of body and mind? Which insights do we get into 
the association between depressive, anxiety and somatic symptoms, its underlying 
mechanisms and its specificity? Which implications do these findings have from a clinical 
and scientific perspective?
Findings in perspective
The association between depressive, anxiety and somatic symptoms
We showed that depressive and anxiety symptoms and somatic symptoms frequently 
co-occur. The prevalence of somatic symptom clusters was two to four times higher in 
patients with a depressive or anxiety disorder compared to persons without a depressive 
or anxiety disorder (Chapter 2). This association was apparent for both cognitive/affective 
and neurovegetative depressive and anxiety symptoms (Chapter 5). Furthermore, 
the co-occurrence has a negative effect on prognosis. We found that persons with 
multiple somatic symptom clusters had a two times higher risk of persistence of a major 
depressive disorder than patients without somatic symptoms (Chapter 4). It is therefore 
not surprising that the co-occurrence was an important subject of conversation between 
patients and physicians in primary care consultations (Chapter 8). The strength and 
consistency of the relation between depressive, anxiety and somatic symptoms underline 
that it is crucial for prevention and treatment programs to take into account all types of 
symptoms in order to improve patients’ outcomes.
Our findings do not only indicate that the association between depressive, anxiety and 
somatic symptoms has negative consequences; they also showed that it could comprise 
an important treatment opportunity. That is, as depressive and anxiety symptoms 
improved during an intervention, somatic symptoms improved simultaneously (Chapter 
10 and 11). We suggested that some of these improvements in somatic symptoms 
could be mediated by direct treatment effects on depressive or anxiety symptoms. For 
instance, the somatic symptom low in energy responded indirectly to the addition of 
pharmacotherapy to psychotherapy, and part of this effect may have been mediated 
by direct treatment effects on the depressive symptoms feeling entrapped or emotional 
lability (Chapter 10). On the other hand, we found that antidepressants indirectly 
effectuated a greater improvement in depressed mood than cognitive behavioral therapy, 
which may partly have been mediated by improvements in general somatic symptoms 
(Chapter 11). Targeting depressive and anxiety symptoms in patients with somatic 
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symptoms or vice versa could therefore be an effective strategy in the treatment of 
patients with both symptom dimensions. In primary care consultations, patients and 
GPs also took advantage of this simultaneous improvement by creating symptom 
management strategies aimed at negative emotions in order to improve somatic 
symptoms (Chapter 8 and 9).
Underlying mechanisms
To improve the outcome of patients with co-occurring depressive, anxiety and somatic 
symptoms, it is crucial to unravel the mechanisms leading to this association. Therefore, 
this thesis explored three mechanisms that have been suggested to explain their co-
occurrence: 1) the symptom types are expressions of the same underlying construct, 
2) they directly influence each other, and 3) they have shared risk factors. The first 
hypothesis that depressive, anxiety and somatic symptoms reflect one underlying 
construct was acknowledged by some patients in consultations for persistent physical 
symptoms, who described these symptoms as an integrated whole with depressive and 
anxiety symptoms (Chapter 8). Our empirical findings, however, provided conflicting 
evidence for this theory. The hypothesis was supported by that specific symptoms 
of the depressive, anxiety as well as somatic domain responded in a similar way to 
interventions (Chapter 10 and 11). In addition, we examined the co-development of 
depressive and anxiety versus functional somatic symptoms during adolescence, as it 
has been suggested that functional symptoms are expressions of depressive and anxiety 
symptoms in children [50]. Indeed, we found patterns of symptom development that 
could be in line with the theory that children learn to interpret and express the signals 
as affective rather than somatic symptoms while they mature (Chapter 2). As we were 
not able to study this underlying mechanism directly, however, our findings form a basis 
for further research.
In contrast to findings that might suggest a common underlying construct, we found that 
depressive and anxiety symptoms more strongly clustered with each other than with 
somatic symptoms (Chapter 2 and 5). Some patients with persistent physical symptoms 
also recognized this distinction between the symptoms as they firmly rejected that 
their somatic symptoms were part of an affective disorder in consultations (Chapter 
8). Still, we found that the clusters of depressive/anxiety and somatic symptoms were 
strongly related (Chapter 2 and 5). This is in accordance with research in a large primary 
care sample [406], which demonstrated that the best fitting factor structure of these 
symptoms consisted of a general factor incorporating shared variance between the 
symptom domains, but also separate factors for depressive, anxiety as well as somatic 
symptoms incorporating their unique variance [406]. Our studies took a more detailed 
look, and demonstrated further heterogeneity within clusters of depressive/anxiety and 
12
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somatic symptoms as individual symptoms showed unique patterns of co-occurrence 
and responses to treatment (Chapter 5, 6, 10, 11). These findings indicate that although 
depressive, anxiety and somatic symptoms may have a common basis that accounts for 
some of their variance, they also have their own specific characteristics. These common 
as well as specific characteristics are captured in a hybrid model [407,408].
Our findings provided some evidence for the second mechanism: depressive, anxiety 
and somatic symptoms directly influence each other [51,178]. This theory was recognized 
by patients with persistent physical symptoms, who frequently described them in primary 
care consultations (Chapter 8). They described relations with unidirectional as well 
as bidirectional causal interferences and referred to vicious circles in which somatic 
symptoms and emotions kept worsening each other. We first examined this theory 
empirically by studying if somatic symptoms could influence depressive symptoms. 
We studied if specific clusters of somatic symptoms predicted the two-year prognosis 
of major depressive disorder (Chapter 4). We found significant predictive effects for 
cardiopulmonary, gastrointestinal and general symptoms. This association did not 
change substantially after adjusting for covariates (e.g., psychiatric characteristics, 
somatic diseases, lifestyle factors and disability; except for a small change after adjusting 
for the severity of baseline depressive symptoms), suggesting that the somatic symptom 
clusters had a direct negative impact on the depressive disorder. This association was 
specific for somatic symptom clusters that were chronic and occurred in combination 
with other clusters (Chapter 4). This might indicate a dose-response effect, which could 
be in line with the theory that symptoms directly influence each other.
Furthermore, we found that psychosocial reasons for encounter in primary care weakly 
predicted if a subsequent health problem constituted FSS (Chapter 7). This might 
indicate that the psychosocial problems caused functional somatic symptoms at a later 
moment in time. Interestingly, this association was not apparent in frequent attenders. 
This probably reflects the complex organization of consultation patterns, which is known 
to be influenced by a considerable number of interacting factors [311-313].
Other indirect support for the theory that symptoms directly impact on each other is 
provided by our finding that somatic symptoms may respond indirectly to an intervention, 
mediated by direct effects of this intervention on depressive and anxiety symptoms, 
and vice versa (Chapter 10 and 11). Interestingly, we found that the core depressive 
symptom depressed mood responded better to the addition of antidepressants to 
psychotherapy compared to psychotherapy alone (Chapter 10) and SSRIs compared 
cognitive behavioral therapy (Chapter 11). These responses seemed not to be direct, 
but indirect via improvements in other symptoms, which could include anxiety or somatic 
symptoms. This indicates that depressed mood may respond to these interventions 
because it is causally related with anxiety and somatic symptoms. These findings 
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highlight the importance of considering such causal trans-dimensional relations to 
understand the effects of interventions on core psychiatric symptoms. As we examined 
the responses of symptoms during the same time period, however, conclusions about the 
temporal ordering of indirect treatment effects are precluded. Still, a recent longitudinal 
study corroborated that somatic symptoms can mediate treatment effects of cognitive 
behavioral therapy for insomnia on depressive symptoms [409]. In order to gain more 
insight into the influence of causal relations among symptoms on their responses to an 
intervention, more longitudinal research with larger samples is warranted.
Finally, we investigated the third mechanism: depressive, anxiety and somatic symptoms 
share risk factors [51,222,410]. We investigated a number of suggested risk factors 
(including sociodemographic characteristics, psychiatric and somatic comorbidity, 
lifestyle, life events, parenting style) and found that none of them explained the co-
occurrence (Chapters 2-4). Previous prospective studies have indicated that the 
magnitude of the effects of these factors on depressive, anxiety and somatic symptoms is 
very small, even though the effects were significant [51,106,107,114,178,228]. Therefore, 
these external factors on their own probably do not have an important role in explaining 
the co-occurrence.
Specificity of associations
It has repeatedly been argued that the complexity of the organization of symptoms 
does not match the rigid definitions of disorders in classification systems [411,412]. This 
realization has supported changes towards a more dimensional classification [411,412]. 
The DSM-5 has for instance abandoned the classification of somatic symptoms based 
on their organ system in somatic symptom disorder, included an anxiety specifier for 
depressive disorder, and introduced cross-cutting symptom dimensions regardless 
of the primary disorder [16,413]. Our findings support such a dimensional approach 
instead of a disorder-focused approach as we showed that all symptoms have common 
characteristics that lead to clustering on varying hierarchical levels between which 
boundaries are fuzzy [232,265,378,406]. For instance, we found that depressive/
anxiety and somatic symptoms formed two dimensions (Chapter 2 and 5), which were 
strongly related. Similarly, although all somatic symptoms were connected within the 
somatic dimension, subdimensions formed based on body systems that did not match 
the categories of chronic fatigue syndrome, fibromyalgia syndrome and irritable bowel 
syndrome (Chapter 5 and 6). The body system subdimensions had both differential and 
similar characteristics. All somatic subdimensions showed for example comparable 
cross-sectional associations to depressive and anxiety disorders (Chapter 3), while only 
three of the four predicted the course of major depressive disorder (Chapter 4).
12
BNW_Ella_V1.indd   221 11-12-19   10:08
222
Chapter 12
Our results also underline that symptom domains are heterogeneous [69,80,93]. This 
heterogeneity was apparent for patterns of co-occurrence and response to treatment. 
For instance, although anxiety and guilt were both part of the cognitive/affective 
subdimension, anxiety showed a ten times stronger association with the somatic 
dimension than guilt (Chapter 5). Furthermore, antidepressants were more effective for 
the depressive symptoms depressed mood and guilt but not thoughts of suicide than 
cognitive behavioral therapy (Chapter 11). That individual symptoms within the same 
symptom domain show differential responses to treatment, even in opposite directions, 
has also been indicated by other work [91,409]. This is not surprising given that some 
somatic symptoms are well-known side effects of psychopharmaceutic agents [414]. 
Still, it underlines that clinically highly important characteristics of specific symptoms 
can be concealed when they are combined into a sum score [69,378].
A dimensional classification favors symptom or syndrome labels over diagnostic labels. 
Interestingly, we showed that most patients used this approach in consultations for 
persistent physical symptoms by referring to their complaints as “fatigue” or “worry” 
instead of “chronic fatigue syndrome” or “anxiety disorder” (Chapter 8). Labels for 
affective disorders that were introduced by physicians could be rejected firmly by 
patients. Nevertheless, other patients openly spoke about their experiences with 
affective disorders. This inconsistency probably reflects the different ways in which 
patients view such labels. Some patients have reported that they feel that labels for 
psychiatric disorders are helpful to remove blame from themselves and indicate that 
treatment options are available [415]. Other patients, however, feel that these labels 
are stigmatizing as they insinuate mind-body dualism and are too simplistic to fully 
explain their symptoms [321]. Furthermore, it has been highlighted that labels can lead 
to medicalization of everyday problems, alienate patients from their experience and 
decrease perceived self-control, and in this way worsen symptoms [61,416]. To avoid 
such unfavorable effects, it has been argued that physicians should introduce labels 
for psychiatric disorders with care [61]. Preferably, the patient and physician create a 
narrative together that captures the symptoms and their underlying mechanisms in the 
patient’s own words [417]. Still, clinical observations indicate that labels are increasingly 
incorporated in patients’ narratives. It should be noted, however, that it is unclear if this 
is a result of the integration of labels in everyday language, or if patients feel that this is 
the appropriate way to communicate with physicians.
Dueling with dualism in clinical care
Due to the ancient dualistic culture in Western medicine, the care for depressive, anxiety 
and somatic symptoms has become splintered. This is apparent from the split between 
psychiatry and somatic disciplines and the tendency of physicians to focus on either field 
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in the consultation [288,418]. This indicates that patients with co-occurring depressive, 
anxiety and somatic symptoms can easily be missed and/or undertreated. Our findings 
therefore stress that physicians from all disciplines should adequately consider this 
co-occurrence in their assessments and management. Nevertheless, some physicians 
have reported to find it challenging to bring up the combination of the symptom domains 
[326,327]. They sometimes unintendedly ignore or block emotional clues of patients with 
somatic symptoms [343], even though such patients typically seek social support [419]. 
To enhance integration of the care for these types of symptoms, important steps have 
been made in health care. Numerous multidisciplinary programs have been developed 
with encouraging effects on overall health [420-423]. A collaborative care treatment 
for depressive symptoms in patients with cancer, for example, lowered depressive 
symptoms, pain and fatigue severity and improved functioning [421]. Furthermore, more 
insight has been derived into the effects of interventions on symptoms from multiple 
dimensions (e.g., Chapter 10 and 11), which could help to identify treatment modalities 
that are most effective for patients with depressive, anxiety as well as somatic symptoms. 
Finally, training programs are currently being developed for general practitioners, who 
have a central role in the treatment of patients with depressive, anxiety as well as 
symptoms [325,362], which strongly focus on communication.
In consultations for patients with depressive, anxiety and somatic symptoms, clinical 
experts commonly advice patient-centered communication [318,356,362]. This 
concentrates on staying closely to the experience of the patient, showing empathy 
and shared decision making [424]. Central is that the patient feels understood and 
supported and is an equal partner in the consultation [424]. Patients have reported that 
they highly value such elements of patient-centered care as it gives them the feeling 
that they are taken seriously [322]. We found that involvement of the patient in the 
creation of management strategies was the most important characteristic associated 
with the adoption of symptom management strategies (Chapter 9). Furthermore, it 
has been shown that patients are much more likely to adopt explanations that are co-
created than those that are created entirely by the physician [425]. This is in line with 
the development of patients’ explanatory models we observed if the physician and the 
patient collaboratively moved towards novel types of explanations (Chapter 8). 
Despite that physicians are frequently encouraged to adopt patient-centered 
communication, it has been demonstrated that some of the recommended pillars for this 
type of communication are inconsistently used in consultations for depressive, anxiety 
and somatic symptoms [343,426-431]. Adopting the network approach as an underlying 
framework may help physicians to adopt a patient-centered communication style. First, 
the approach encourages physicians to concentrate on symptoms that are relevant to 
the specific patient, as well as external triggers and causal relations that the patient has 
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experienced. In addition, symptoms in a network can be ordered according to view of 
the patient and, therefore, it may come naturally to avoid the use of diagnostic labels 
or dualism embedded in the medical realm. Third, since a network consists of small 
building blocks (symptoms) instead of large constructs (disorders), it may be easier 
to identify targets for treatment that seem manageable. Finally, the network approach 
advocates low-intensity treatment like symptom management strategies instead of long 
psychotherapies or medication, as small interventions can have dramatic effects via 
ongoing feedback loops among symptoms [15].
A potentially valuable tool to incorporate the network approach into clinical care is a data-
driven network that can be constructed if a patient monitors symptoms during several 
weeks with ecological momentary assessment [15,84,432,433,433]. Such a personalized 
network provides a draft of the way symptoms and external triggers may interact in a 
specific individual, and can be used as a basis to create a person-specific network that 
is accordance with the experience of the patient. This person-specific network can 
be used in treatment to identify potential targets for interventions on three levels: 1) 
external triggers of symptoms, 2) central symptoms, or 3) connections among symptoms 
[15]. Trying to eliminate external triggers, for example by solving relational problems 
that triggered worry, is a good starting point. However, not all external triggers can 
be removed, and feedback loops among symptoms might continue even after triggers 
have been eliminated. The next step is to treat specific symptoms, especially if they are 
central in the network. For example, a short treatment of hot flushes in a depressed 
postmenopausal woman with hormone replacement therapy might improve insomnia and 
result in a cascade of improvements in other symptoms (less fatigue, more concentration, 
and less guilt, worry and sadness). In this context, interventions specifically targeted at 
individual symptoms such as web-based mini-interventions for worry and insomnia are 
highly promising [434]. A final treatment option is to target connections in the network, 
such as feeling guilty over concentration problems. In this instance, cognitive techniques 
to lessen the tendency of an individual to blame themselves could give symptoms the 
opportunity to recover and help to build resilience for when symptoms recur. Before 
data-driven networks can be implemented as a tool in clinical care, however, exploratory 
research on several fundamental terrains is warranted, including whether the graphs 
offer more insight into mechanisms underlying symptoms than a regular consultation, 
and whether they are feasible to use in time-restrained consultations.
By identifying specific targets for treatment, the application of the network approach 
could also help to identify interventions that are likely to be effective for an individual 
patient [433]. We found that this “precision medicine” has the potential to increase 
efficacy of interventions for depressive symptoms (Chapter 11). Furthermore, tailoring 
symptom management to the patient’s narrative seemed to be an important prerequisite 
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for the adoption of strategies (Chapter 9). An easily applicable way to personalize 
treatment in clinical care is to focus on symptom profiles of patients. Our findings 
indicated for example that SSRIs were more effective in the treatment of patients with 
specific depressive, anxiety and somatic symptoms (e.g., thoughts of suicide, panic, 
general somatic symptoms) than cognitive behavioral therapy (Chapter 11). Taking into 
account such responses of differential (types of) symptoms to interventions could help 
to balance whether the burden and side effects of an intervention outweigh its potential 
benefits for a particular person. In this respect, focusing on symptom dimensions such as 
cognitive/affective, neurovegetative and musculoskeletal symptoms has the advantage 
of offering parsimonious information that can easily be converted to clinical practice. 
However, individual symptoms capture a higher level of heterogeneity and, because they 
have varying levels of clinical urgency, could help to predict the benefits of an intervention 
for a person more specifically. For example, suicidality is of higher importance to target 
with an intervention than concentration problems, while the latter is more urgent when 
a patient’s job requires a high concentration level than when the job does not.
Methodological considerations
For the interpretation of the results of this thesis, several methodological aspects 
should be taken into account. Although we have discussed various issues in detail in 
the corresponding chapters, we would like to highlight some considerations that need 
further reflection.
This thesis made use of several databases that were restricted to specific situations and 
populations. Examples include the extended set of consultations with specially trained 
GPs and patients with multiple persistent physical symptoms (Chapter 8 and 9) and the 
sample of patients with a mild to moderate depressive disorder (Chapter 10). A limitation 
of this focus is that it reduces the generalizability of the results to, for instance, regular 
primary care consultations with patients with persistent physical symptoms (Chapter 
8 and 9) and all patients with a depressive disorder (Chapter 10). This underlines the 
strength of the population based databases that were used for others studies in this 
thesis (Chapter 2 and 6). Furthermore, most databases focused on patients with one 
primary type of symptoms, such as persistent physical symptoms or a depressive 
disorder. Although patients with one of these types of symptoms often also report other 
types of symptoms addressed in this thesis, it is important to keep in mind these studies 
did not focus explicitly on patients who reported the combination of depressive, anxiety 
and/or somatic symptoms. An exception is the NESDA database (Chapter 3, 4 and 5) 
[172], which included patients with depressive as well as anxiety disorders. To increase 
insight into the population of patients with the co-occurrence of depressive, anxiety and 
somatic symptoms, more studies with a transdiagnostic inclusion process are warranted.
12
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Another limitation includes that it was difficult to differentiate between somatic symptoms 
sufficiently and insufficiently explained by somatic or psychiatric disorders. To determine 
which somatic symptoms were functional, we used self-report questionnaires (e.g. 
Chapter 2) as well as diagnostic codes registered by GPs in electronic records (e.g. 
Chapter 7). Even though a clinical assessment by a GP may more reliably indicate if 
a symptom is or is not sufficiently explained by diseases than the answer of a patient 
to a brief question without further explanation about these symptoms, both methods 
are not fully reliable. This problem reflects the difficulty in clinical practice to establish 
if a symptom is sufficiently explained by somatic or psychiatric diseases. As the 
presentation of diseases strongly differs across patients (take for instance the poor 
correlation between abnormalities on MRIs and experienced pain in patient with a 
spinal disc herniation) [30], it is difficult to determine if a symptom is more severe or 
persistent than can be expected based on a particular disease. Furthermore, due to 
varying opinions across clinicians about with which level of certainty a symptom can 
be classified as functional [30], it is challenging to formulate one uniform definition of 
functional somatic symptoms. Several important classification systems have shifted their 
focus to the presence of multiple and/or persistent somatic symptoms that are disturbing 
for the patient, independent of whether these symptoms are explained or unexplained 
by disorders [16, 43]. This approach of neglecting the presence of underlying diseases 
but focusing on what is observed (i.e., the symptom), which was adopted in several 
studies of this thesis (Chapters 3, 4, 5, 6, 8, 9, 10 and 11), is highly promising to increase 
uniformity in research and clinical practice.
Several chapters of this thesis concentrated on the differential characteristics of 
individual depressive, anxiety and/or somatic symptoms. This focus increased insight 
into symptom-specific characteristics, but it increased also the number of conducted 
tests and, therefore, the risk of type I errors [435]. We used regularization in network 
models to lower this risk [398]. However, it has been questioned whether this method 
is strict enough, especially in the study of treatment effects [436,437]. We did not use 
stricter corrections for multiple testing because of the exploratory nature of our research 
questions. Therefore, it is important to keep in mind that hypothesis-testing studies are 
needed to confirm some hypotheses that have been generated by our studies.
A final consideration is related to our use of individual items of rating scales to measure 
specific symptoms. As these scales have been designed for analyses with scale scores, 
they have several limitations in the analysis of individual symptoms. First, the inter-
rater reliability of single items has been questioned [69,437,438]. Second, as some 
scales measure only the frequency of symptoms (e.g., the Four-Dimensional Symptom 
Questionnaire [174]), the items’ clinical relevance in terms of associated distress and 
functional impairment remains unclear. The absence of cut-offs for clinical relevance and 
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variation in answering categories in some rating scales is also suboptimal [274]. Finally, 
as individual items vary considerably across scales [66], it is difficult to compare the 
results of studies based on different scales. For future studies on individual symptoms, 
it is essential to increase the quality of assessment, for instance with a novel scale 
which assesses individual symptoms with multiple items [69]. The development of such 
a scale offers the opportunity to adopt a multidimensional approach in which there is 
attention for symptoms that have empirically or historically been highlighted but are not 
included in current classification systems (e.g., the frustration and embarrassment which 
were frequently described by patients with persistent physical symptoms [Chapter 8]) 
[54,236,403].
Directions for research
This thesis postulated several hypotheses to explain the relation between depressive, 
anxiety and somatic symptoms. More prospective studies are needed to determine 
whether these mechanisms indeed explain the co-occurrence. In contrast to generalizing 
mechanisms to all patients with depressive, anxiety as well as somatic symptoms, 
it should be considered that it is also possible that the mechanisms explain the co-
occurrence in specific individuals and contexts. We found that patients recognized this 
heterogeneity as their described relations between persistent physical symptoms and 
emotions in consultations differed across persons, symptoms and situations (Chapter 
8). That explanations can be person- and symptom-specific has also been empirically 
confirmed. Ecological momentary assessment studies have indicated that low mood has 
a stronger temporal association with fatigue than stress [439], and that this association 
with stress is strong in some individuals but absent in others [440]. This specificity of 
mechanisms stresses that it is key to identify which explanations fit which patient, for 
which ecological momentary assessment has significant potential [441].
A second issue that should be considered is that not isolated mechanisms, but rather 
the cumulative effects of their dynamic interplay may lead to the co-occurrence of 
depressive, anxiety and somatic symptoms. This dynamic conceptualization of medicine 
has an intuitive fit with clinical reality [442]. For instance, it could explain that some 
patients are stable for a long time but relapse very rapidly after a relatively minor event 
in their life [443-446]. Although this complex system approach is gaining attention in 
the literature, empirical support remains sparse. One promising validation method is to 
search for the heavy-tailed data distribution that is characteristic for a complex system 
[295,296,447]. This distribution is in line with that depressed patients have either low or 
high symptom levels [448], but has to our knowledge never been studied for anxiety and 
somatic symptoms. Second, according to the complex systems theory, the co-occurrence 
of depressive, anxiety and somatic symptoms is more likely to occur in persons with 
12
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stronger cross-connections in a network between these symptom domains than 
persons with weaker cross-connections [449]. Studying whether the strength of cross-
connections is associated with the development of the co-occurrence of depressive, 
anxiety and somatic symptoms, both across persons and within persons over time, is 
therefore an interesting validation method [444]. The principles of the complex system 
approach can also be applied to patients’ consultation patterns, for instance by using 
complexity measures (Chapter 7) [295,299]. An interesting topic is if patients with a more 
complex (i.e., more diverse) consultation pattern have a higher risk of sudden bursts of 
consultations than persons with a less complex consultation pattern.
As network analysis is a novel approach in research, many topics remain open for 
study. Firstly, network studies that have so far been conducted have mainly focused 
on symptoms and, as such, often ignored the potential effects of external factors. 
Recently, statistical methods have been developed to combine symptoms with external 
factors in one network [450]. By combining symptoms as well as external factors such 
as biological, psychological, social and existential factors in one multi-layered hybrid 
model [407,408], it is possible to identify common underlying constructs, direct symptom-
symptom interactions, and shared risk factors that might play a significant role in the 
relation between depressive, anxiety and somatic symptoms. Authors have so far also 
focused on networks within persons, while interactions among people could influence 
this [451]. Therefore, future studies could focus on the way a network of a person is 
affected by a higher-order system of interacting people, ranging from the impact of 
a head-to-head conversation with a physician to cultural influence. Furthermore, the 
network approach has been introduced with symptoms and external factors with negative 
influence as elements of the system [55,452,453]. However, positive sensations and 
prognostically favorable external factors are indispensable parts of daily life and the 
symptom’s development [454,455]. Therefore, they should be included in network models 
too. Besides that this would provide a richer overview of the dynamics within a person, 
it could also help to highlight the positive sides of elements that are typically depicted 
as negative in medicine. For instance, depressive symptoms have been claimed to help 
people solve complex problems by minimizing disruption of rumination and sustaining 
analysis of the problem [456].
Although statistical methods for the construction of networks can help to explain 
processes underlying symptoms, it should be considered that symptoms and their 
underlying mechanisms constitute a personal experience and have a meaning and 
a purpose to people. How factors are observed by the outside world reflects different 
patient realities and meanings, which are highly relevant in clinical care [408,457]. To 
gain more insight into this understanding of symptoms and their underlying mechanisms, 
it is important to combine a quantitative focus with qualitative methods, for example by 
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analyzing patient’s narratives [458,459]. This becomes apparent from the way patients 
described persistent physical symptoms and emotions in consultations (Chapter 8). 
Although these types of symptoms are seen as distinct categories in the medical realm, 
some patients completely integrated the two in their narratives. It should therefore be kept 
in mind that the way a typical network model is set up (i.e., with individual symptoms) may 
not compel with the view of each patient. In order to align with the patient in ecological 
momentary assessment, it would be best to discuss such assumptions beforehand and 
adjust the questionnaire to the patient’s point of view.
Although clinical guidelines typically recommend the use of symptom management 
strategies, antidepressants or cognitive behavioral therapy for patients with depressive, 
anxiety and somatic symptoms [289,460,461], little is known about which of the 
options has the highest efficacy for particular patients. While we have considered 
the symptom-specific effects of antidepressants and psychotherapy in persons with 
a primary depressive disorder, future research could focus on: a) the effects of other 
interventions, on b) a broader spectrum of symptoms, in c) patients with co-occurring 
depressive, anxiety and somatic symptoms. One interesting comparison would be the 
relative efficacy of varying types of antidepressants. Although it is common knowledge 
that TCAs are more effective for pain symptoms but have more anticholinergic side 
effects than SSRIs [462,463], less is known about their relative effects on other specific 
depressive, anxiety and somatic symptoms. Studies focusing on the effects of such 
drug classes on more types of symptoms could help to increase insight into which 
interventions may be most effective for which patients with co-occurring depressive, 
anxiety and somatic symptoms.
A future perspective
In the historical perspective, it became apparent that numerous conceptualizations of 
the relation between depressive, anxiety and somatic symptoms have dominated the 
medical realm throughout history [1]. In recent decades, the biopsychosocial model has 
attempted to supersede the reductionist biomedical model, but has not fully succeeded 
[5]. Many authors have called for a multidimensional, multifactorial and dynamic 
conceptualization of medicine [8,55,446,464,465]. The complex systems approach 
in the network perspective may be this conceptualization. It abandons categorical 
classifications, allows for the consideration of factors from many different levels (e.g., 
biological, psychological, social, existential levels) and provides a rationale for the non-
linear development of pathology [15]. Furthermore, in this discussion we explained that 
the approach might help to enhance patient-centered communication and personalization 
of treatment. As such, it may be the key to increase knowledge about the co-occurrence 
between depressive, anxiety and somatic symptoms, both regarding its epidemiological 
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and clinical aspects. The promise of the approach is reflected in the booming literature 
on its conceptualizations and potential applications [94]. More of such work is needed in 
order to investigate the basic assumptions and statistical underpinnings of the approach. 
Currently, however, the most important challenge lies in the translation of the conceptual 
model to everyday clinical practice for physicians.
A final note
We end this thesis by taking a step back. The way we view depressive, anxiety and 
somatic symptoms is not static. Theories changed throughout history: somatic theories 
originated in physically-oriented Antiques medicine, machine-like theories were created 
in the Industrial Age, and brain disease theories thrived together with brain investigations 
[1]. In this context, the complex system theory fits well with the 21st century’s focus on 
complex systems among people via social media, economies via import and export 
and countries via flight paths. Similarly, where previous labels suggested a biomedical 
underlying mechanism (“hysteria” was derived from the Greek word for uterus), labels 
from the current imaging era tend to emphasize what is or is not observed (“medically 
unexplained symptoms” or, more recently, “persistent physical symptoms”) [1]. That 
approaches in medicine are subject to changes teaches us that our conceptualization 
resembles a well substantiated mind map more than the reality. This map is an 
indispensable basis to get a grip on reality and to shape health care. However, we 
should not lean too heavily on it. Instead of imposing our medical conceptualizations and 
labels on patients, we should listen to their ideas and engage in a dialogue to formulate 
explanations together. This interplay between the patient and the physician designs the 
most fruitful body-mind maps.
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